Skip to main content
Clinical Trials/NCT07074730
NCT07074730
Recruiting
Not Applicable

General Anesthesia Versus Spinal Anesthesia With Local Anesthetic Infiltration for Buccal Mucosal Graft in Urethroplasty: A Randomized Controlled Trial

Tanta University1 site in 1 country100 target enrollmentStarted: July 19, 2025Last updated:

Overview

Phase
Not Applicable
Status
Recruiting
Enrollment
100
Locations
1
Primary Endpoint
Degree of pain

Overview

Brief Summary

This study aims to compare general anesthesia and spinal anesthesia with local anesthetic infiltration for buccal mucosal graft (BMG) in urethroplasty.

Detailed Description

Urethroplasty is a surgical procedure aimed at reconstructing the urethra and is considered the standard treatment for bulbar urethral strictures, with different types of tissues used as either grafts or flaps, affecting approximately 300 per 100,000 males.

Postoperative pain following urethroplasty with buccal mucosal graft (BMG) is primarily related to the oral graft harvest site.

General Anesthesia provides a state of complete unconsciousness, ensuring that patients are free from pain and awareness during the surgery. It can be beneficial in complex cases or when extended manipulation is required, allowing for muscle relaxation and controlled ventilation.

On the other hand, spinal anesthesia involves the injection of anesthesia into the cerebrospinal fluid, resulting in targeted numbness in the lower body. This technique can be advantageous for its fast, simple, cost-effective method, rapid onset, lower risk of systemic complications, and preservation of airway reflexes.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
21 Years to — (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Male patient age ≥ 21 years.
  • American Society of Anesthesiologists (ASA) classification I-II.
  • Patient scheduled for urethroplasty.

Exclusion Criteria

  • Patients who are taking analgesics for chronic illness or have a history of substance abuse.
  • Patients who are unable to describe their postoperative pain (e.g., neuropsychiatric disorder).
  • Patients with known local anesthetics and opioid allergy.
  • Patients with infection at the site of the needle puncture.

Outcomes

Primary Outcomes

Degree of pain

Time Frame: 24 hours postoperatively

Each patient will be instructed about postoperative pain assessment with the Numerical rating Scale (NRS). NRS (0 represents "no pain"; (1-3) mild pain; (4-6) moderate pain; (7-10) severe pain. NRS will be assessed at 0, 4, 8, 12, 18 and 24h postoperatively.

Secondary Outcomes

  • Postoperative morphine consumption(24 hours postoperatively)
  • Operative time(Till discharge to post-anesthesia care unit (Up to 2 hours))
  • Length of hospital stay(Till discharge from hospital (Up to one week).)
  • Patient satisfaction(24 hours postoperatively)
  • Incidence of complications(24 hours postoperatively)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Aya Allah Hamdy Elbahy

Assistant lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt.

Tanta University

Study Sites (1)

Loading locations...

Similar Trials